Geode Capital Management’s Adverum Biotechnologies ADVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$397K Sell
184,762
-266,496
-59% -$573K ﹤0.01% 3630
2025
Q1
$1.97M Buy
451,258
+8,768
+2% +$38.3K ﹤0.01% 3034
2024
Q4
$2.07M Buy
442,490
+3,434
+0.8% +$16K ﹤0.01% 3107
2024
Q3
$3.08M Sell
439,056
-16,731
-4% -$117K ﹤0.01% 2976
2024
Q2
$3.13M Buy
455,787
+262,271
+136% +$1.8M ﹤0.01% 2963
2024
Q1
$2.74M Buy
193,516
+107,095
+124% +$1.51M ﹤0.01% 2988
2023
Q4
$651K Hold
86,421
﹤0.01% 3519
2023
Q3
$1.3M Sell
86,421
-2,284
-3% -$34.3K ﹤0.01% 3223
2023
Q2
$1.41M Buy
88,705
+9,915
+13% +$158K ﹤0.01% 3222
2023
Q1
$565K Buy
78,790
+1,575
+2% +$11.3K ﹤0.01% 3595
2022
Q4
$447K Buy
77,215
+1,656
+2% +$9.59K ﹤0.01% 3709
2022
Q3
$717K Buy
75,559
+259
+0.3% +$2.46K ﹤0.01% 3552
2022
Q2
$903K Sell
75,300
-67,264
-47% -$807K ﹤0.01% 3474
2022
Q1
$1.87M Sell
142,564
-15,189
-10% -$199K ﹤0.01% 3289
2021
Q4
$2.78M Buy
157,753
+4,360
+3% +$76.7K ﹤0.01% 3205
2021
Q3
$3.33M Sell
153,393
-6,676
-4% -$145K ﹤0.01% 3142
2021
Q2
$5.6M Buy
160,069
+9,702
+6% +$340K ﹤0.01% 2822
2021
Q1
$14.8M Buy
150,367
+13,926
+10% +$1.37M ﹤0.01% 2073
2020
Q4
$14.8M Buy
136,441
+6,747
+5% +$731K ﹤0.01% 1900
2020
Q3
$13.4M Buy
129,694
+24,986
+24% +$2.57M ﹤0.01% 1784
2020
Q2
$21.9M Buy
104,708
+13,761
+15% +$2.87M ﹤0.01% 1454
2020
Q1
$8.89M Buy
90,947
+13,968
+18% +$1.36M ﹤0.01% 1804
2019
Q4
$8.87M Sell
76,979
-4,315
-5% -$497K ﹤0.01% 2093
2019
Q3
$4.43M Buy
81,294
+346
+0.4% +$18.9K ﹤0.01% 2453
2019
Q2
$9.62M Buy
80,948
+1,686
+2% +$200K ﹤0.01% 1983
2019
Q1
$4.15M Buy
79,262
+9,402
+13% +$493K ﹤0.01% 2437
2018
Q4
$2.2M Buy
69,860
+11,517
+20% +$363K ﹤0.01% 2724
2018
Q3
$3.53M Buy
58,343
+12,383
+27% +$749K ﹤0.01% 2582
2018
Q2
$2.44M Buy
45,960
+17,825
+63% +$944K ﹤0.01% 2742
2018
Q1
$1.63M Buy
28,135
+18,610
+195% +$1.08M ﹤0.01% 2874
2017
Q4
$333K Hold
9,525
﹤0.01% 3503
2017
Q3
$347K Hold
9,525
﹤0.01% 3481
2017
Q2
$238K Sell
9,525
-4,001
-30% -$100K ﹤0.01% 3615
2017
Q1
$365K Buy
13,526
+408
+3% +$11K ﹤0.01% 3433
2016
Q4
$380K Buy
13,118
+662
+5% +$19.2K ﹤0.01% 3371
2016
Q3
$511K Buy
12,456
+219
+2% +$8.98K ﹤0.01% 3242
2016
Q2
$386K Buy
12,237
+2,719
+29% +$85.8K ﹤0.01% 3328
2016
Q1
$492 Buy
9,518
+145
+2% +$7 ﹤0.01% 3246
2015
Q4
$892K Buy
9,373
+2,022
+28% +$192K ﹤0.01% 2969
2015
Q3
$604K Buy
7,351
+490
+7% +$40.3K ﹤0.01% 3130
2015
Q2
$1.11M Buy
6,861
+1,264
+23% +$205K ﹤0.01% 2835
2015
Q1
$2.27M Buy
5,597
+1,122
+25% +$454K ﹤0.01% 2359
2014
Q4
$2.42M Buy
4,475
+1,078
+32% +$582K ﹤0.01% 2310
2014
Q3
$1.16M Buy
+3,397
New +$1.16M ﹤0.01% 2695